CORCEPT THERAPEUTICS INC 8-K

What Happened

• Corcept Therapeutics Incorporated (CORT) filed a Form 8-K (Item 7.01) on April 30, 2026 to disclose under Regulation FD that it issued a press release announcing its financial results for the quarter ended March 31, 2026 and a corporate update. The press release is attached to the filing as Exhibit 99.1 and is incorporated by reference.

Key Details

• Filing date: April 30, 2026 (Form 8-K).
• Period covered: quarter ended March 31, 2026 (Q3 2026).
• Exhibit: Press Release of Corcept Therapeutics Incorporated dated April 30, 2026 (Exhibit 99.1).
• Administrative: XBRL cover page tags are embedded; Form 8-K signed by Atabak Mokari, Chief Financial Officer.

Why It Matters

• The company publicly released its quarterly earnings and a corporate update; investors should read the attached press release for specific figures on revenue, earnings and any guidance or strategic updates. Because this disclosure was made under Regulation FD and filed on Form 8-K, the information is official and public. Review the press release (Exhibit 99.1) and subsequent SEC filings for full financial details and implications for CORT shares.